Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Stock Has Average Price Target of $197.50 According to Brokerages

Shares of Sol-Gel Technologies Ltd. (NASDAQ:SLGL) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $197.50.

SLGL has been the subject of a number of recent research reports. HC Wainwright restated a “buy” rating and issued a $110.00 price objective on shares of Sol-Gel Technologies in a report on Monday, July 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Sol-Gel Technologies in a report on Tuesday, September 1st. Finally, Mizuho began coverage on shares of Sol-Gel Technologies in a research report on Wednesday, June 24th. They issued an “outperform” rating and a $285.00 target price on the stock.

Insider Activity

In related news, major shareholder Opaleye Management Inc. acquired 35,113 shares of Sol-Gel Technologies stock in a transaction dated Friday, August 28th. The shares were purchased at an average cost of $69.32 per share, with a total value of $2,434,033.16. Following the completion of the purchase, the insider owned 520,000 shares of the company’s stock, valued at $36,046,400. This represents a 7.24% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders bought 53,959 shares of company stock worth $3,723,781 over the last quarter. 66.51% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Sol-Gel Technologies

A hedge fund recently bought a new stake in Sol-Gel Technologies stock. Affinity Asset Advisors LLC purchased a new position in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 35,000 shares of the company’s stock, valued at approximately $2,773,000. Affinity Asset Advisors LLC owned 1.25% of Sol-Gel Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 26.18% of the company’s stock.

Sol-Gel Technologies Trading Down 1.4%

Shares of Sol-Gel Technologies stock opened at $72.00 on Thursday. The firm has a market capitalization of $202.32 million, a PE ratio of -12.77 and a beta of 1.14. Sol-Gel Technologies has a 12 month low of $28.50 and a 12 month high of $97.97. The business’s 50-day moving average price is $73.96 and its 200-day moving average price is $74.44.

Sol-Gel Technologies (NASDAQ:SLGL) last released its earnings results on Friday, August 21st. The company reported ($1.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.36) by $1.23. Sol-Gel Technologies had a negative return on equity of 44.05% and a negative net margin of 910.14%.The company had revenue of $0.59 million during the quarter, compared to the consensus estimate of $0.07 million. As a group, analysts predict that Sol-Gel Technologies will post -4.95 earnings per share for the current fiscal year.

Sol-Gel Technologies Company Profile

Sol-Gel Technologies Ltd. is an Israeli specialty pharmaceutical company focused on developing topical dermatological treatments. The company uses proprietary microencapsulation technology designed to improve the delivery, stability, and tolerability of active pharmaceutical ingredients applied to the skin.

Sol-Gel’s products include TWYNEO Cream, a topical combination of tretinoin and benzoyl peroxide for acne, and EPSOLAY Cream, a microencapsulated benzoyl peroxide treatment for inflammatory lesions associated with rosacea.